Geneva, June 22 -- International Clinical Trials Registry received information related to the study (NCT07644637) titled 'BELLRICU PROJECT: Precision Medicine in Respiratory Intermediate Care Units' on June 9.
Study Type: Observational [Patient Registry]
Primary Sponsor: Hospital Universitari de Bellvitge
Condition:
Acute Respiratory Failure (ARF)
Intermediate Respiratory Care Unit
Respiratory Precision Medicine
Mortality Prediction
Stratification Risk
Recruitment Status: Not recruiting
Date of First Enrollment: June 10, 2026
Target Sample Size: 624
Countries of Recruitment:
Spain
To know more, visit https://clinicaltrials.gov/study/NCT07644637
Published by HT Digital Content Services with permission from Health Daily Digest....